August 2024
M	T	W	T	F	S	S
	1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Insight

Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma

Photo taken from bioworld.com

Aug 24, 2024, 06:23

Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma

Raul Cordoba shared on X:

“Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.”

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Authors: Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés JMFerreri, Francesco Merli, Weili Zhao, Luigi Rigacci, Claudia Cellini, David Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trneny, Franco Cavalli, Mary Gospodarowicz, Peter WM Johnson, Andrew Davies, and Emanuele Zucca

B-Cell Lymphoma

Source: Raul Cordoba/X

For more posts about B-Cell Lymphoma, visit oncodaily.com

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Coordinator of the Lymphoma Unit at University Hospital Fundación Jiménez Díaz, Madrid, Spain.

He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.